The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.73BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
3.78BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-2.77%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Beta
1.34x
vs all stocks
Updated Oct 28, 2026
52-Week Change
-19.52%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
14.73BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
15.97BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
15.27x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Price to Sales (TTM)
3.89x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Price to Book (MRQ)
2.88x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Enterprise to Revenue
4.22x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Enterprise to EBITDA
18.15x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Gross Margin
69.43%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 71.77%.Updated Oct 28, 2026
Profit Margin
-2.77%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Operating Margin
15.13%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Return on Assets (TTM)
4.80%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Return on Equity (TTM)
-1.94%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Revenue (TTM)
3.78BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
16.05USDUpdated Oct 28, 2026
Quarterly Revenue Growth
11.00%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Gross Profit (TTM)
2.72BUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
868.20MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-104.70MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
11.00%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Operating Cash Flow (TTM)
799.10MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
686.17MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Revenue
3.59BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.11BUSDFY2025 · Dec 31, 2025
Gross Profit
2.48BUSDFY2025 · Dec 31, 2025
Operating Income
611.30MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
509.40MUSDFY2025 · Dec 31, 2025
Income Tax Expense
85.40MUSDFY2025 · Dec 31, 2025
Net Income
424.00MUSDFY2025 · Dec 31, 2025
EBIT
583.80MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
800.00MUSDFY2025 · Dec 31, 2025
Research & Development
630.70MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.13BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
74.40MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.77USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.76USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
239.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
239.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
424.00MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
722.90MUSDFY2025 · Dec 31, 2025
Free Cash Flow
697.60MUSDDerived from operating cash flow minus capital expenditure. This filing charges 199.9M of depreciation against 25.3M of capital expenditure, and its own free-cash-flow line reads 360.9M.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
253.40MUSDFY2025 · Dec 31, 2025
Income Tax Paid
427.50MUSDFY2025 · Dec 31, 2025
Interest Paid
81.50MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
424.00MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
199.90MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
2.30MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
146.50MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
88.50MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-119.90MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-5.40MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-13.00MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-25.30MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-8.80MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-2.90MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-37.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
577.20MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-577.20MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-863.40MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-5.60MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-868.40MUSDFY2025 · Dec 31, 2025
Shares Outstanding
233.20MSharesUpdated Oct 28, 2026
Float Shares
231.95MSharesUpdated Oct 28, 2026
Shares Short
9.48MSharesUpdated Oct 28, 2026
Short Ratio
4.30days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
4.70%
vs all stocks
Updated Oct 28, 2026
% Held by Insiders
0.40%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
102.51%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
214.40MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
0.9190USDUpdated Oct 28, 2026
Total Debt (MRQ)
1.46BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.2855x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Current Ratio (MRQ)
0.9540x
vs Scientific & Technical Instruments peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
21.92USDUpdated Oct 28, 2026
Total Assets
9.31BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.63BUSDFY2025 · Dec 31, 2025
Total Liabilities
3.48BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
7.68BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.97BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.50BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
253.40MUSDFY2025 · Dec 31, 2025
Accounts Receivable
856.00MUSDFY2025 · Dec 31, 2025
Inventory
186.30MUSDFY2025 · Dec 31, 2025
Accounts Payable
168.30MUSDFY2025 · Dec 31, 2025
Deferred Revenue
894.00MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
211.70MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.39BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
285.00MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
200.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
3.39BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
5.84BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
47.92USDUpdated Oct 28, 2026
52-Week High
84.42USDUpdated Oct 28, 2026
52-Week Change
-19.52%
vs all stocks
Updated Oct 28, 2026
Beta
1.34x
vs all stocks
Updated Oct 28, 2026
50-Day MA
59.46USDUpdated Oct 28, 2026
200-Day MA
61.06USDUpdated Oct 28, 2026
Avg 10-Day Volume
1.70MSharesUpdated Oct 28, 2026
Avg 30-Day Volume
2.08MSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-0.4800USDUpdated Oct 28, 2026
Other Income / Expense
-27.50MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 69.4%, higher than 95% of its Scientific & Technical Instruments peers (median 39.9%)Significant